GlassScriptPhysician profile
Christopher P Brenner
NPI 1629020102
$750.43
in general payments reported to CMS, 2019-2025
16 companies · $535 in 2025
The $535 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.45 · 2020: $22.27 · 2022: $24.97 · 2024: $138 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $113.23 | 2024-2025 | Krystexxa, Otezla, Repatha |
| Pfizer INC. | $84.31 | 2024-2025 | |
| Lilly USA, LLC | $80.43 | 2024-2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $78.19 | 2025 | Rexulti |
| Exact Sciences Corporation | $57.26 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $57.17 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $54.37 | 2025 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.10 | 2025 | Caplyta |
| Abbvie INC. | $37.08 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.45 | 2019 | |
| Heron Therapeutics, INC. | $24.97 | 2022 | |
| Angiodynamics, INC. | $22.27 | 2020 | |
| Glaxosmithkline, LLC. | $17.68 | 2024 | Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $16.60 | 2025 | Inspire |
| Radius Health, INC. | $16.17 | 2025 | Tymlos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.15 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.